Redcare Pharmacy NV reported Q1 2026 group revenue of €848 million, up 18.3% YoY from €717 million.
German prescription drug sales surged 55% YoY to €168 million, driving overall revenue growth and expanding e‑Rx market share.
Active customers rose 8% YoY to 14.2 million, while e‑Rx NPS improved to 76, confirming 2026 guidance.
DACH segment revenue increased 18.9% to €692 million, with Rx revenue up 35% and non‑Rx up 8.1% YoY.